Evidence map›Paper›PMID 23265432›Full record

ArticleAIDS research and human retroviruses2013

Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire.

Matthew S Parsons, Robert J Center, Jean-Pierre Routy, Danielle Rouleau, Roger Leblanc, Mark A Wainberg, Cécile L Tremblay, Marcel D Zannou, Stephen J Kent, Michael D Grant and 1 more

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Matthew S ParsonsResearch Institute of the McGill University Health Centre, Montréal, Québec, Canada.
Robert J Center
Jean-Pierre Routy
Danielle Rouleau
Roger Leblanc
Mark A Wainberg
Cécile L Tremblay
Marcel D Zannou
Stephen J Kent
Michael D Grant
Nicole F Bernard
McGill University Health Centre · CAThe University of Melbourne · AUMemorial University of Newfoundland · CAJewish General Hospital · CAUniversité d'Abomey-Calavi · BJ

Funding

Canadian Institutes of Health Research HPR-85528Canadian Institutes of Health Research MOP-79515Canadian Institutes of Health Research MOP-93770
6 · The paper itself

Abstract

A common idiotype of anti-HIV antibodies (Abs), designated as 1F7, was recently observed on anti-HIV broadly neutralizing Abs (BnAbs). The presence of the 1F7-idiotype on BnAbs suggests that continuous selection of 1F7-idiotypic Abs may allow these clones to achieve the somatic hypermutation necessary for broad neutralization. As the selection of type-specific BnAbs occurs in the setting of infections with a wide array of HIV subtypes, we investigated Abs from subjects infected with diverse subtypes for the selection of 1F7-idiotypic Abs. We observed the 1F7-idiotype on antiviral Abs in infections with various HIV subtypes. Furthermore, gp140-specific 1F7-idiotypic Abs recognized the gp140 antigens from several HIV subtypes. These results demonstrate that the 1F7-idiotype is a common characteristic of Abs from infections with diverse HIV subtypes, and suggests that early cross-reactivity of 1F7-idiotypic clones may act in conjunction with somatic hypermutation to produce BnAbs.

Indexed as

Antibody FormationHIV-1HIV AntibodiesHIV InfectionsHumansImmunoglobulin IdiotypesViral Envelope ProteinsHIV AntibodiesImmunoglobulin IdiotypesViral Envelope Proteins

Identifiers

PMID23265432
PMCPMC3636582
OpenAlexW1994346073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.